Purchases and Sales Made in Q1 2023 in Talis Biomedical Corp (TLIS)
This table provides information about the institutional ownership of Talis Biomedical Corp (TLIS) during Q1 2023. The information is specifically focused on institutions that hold shares of Talis Biomedical Corp.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 15, 2023
Q1 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
52.6K+ 47.4% |
$25.3K - $33.7K
|
164K
$257K
|
|
May 12, 2023
Q1 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
7.6K+ 21.78% |
$3.65K - $4.86K
|
42.5K
$66.7K
|
|
May 15, 2023
Q1 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
1.26K+ 2.12% |
$606 - $808
|
60.9K
$95.5K
|
|
May 09, 2023
Q1 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
527New |
$253 - $337
|
527
$827
|
|
May 12, 2023
Q1 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
3+ 1.83% |
$1.44 - $1.92
|
167
$262
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
May 15, 2023
Q1 2023
|
Mercer Global Advisors Inc
Denver, CO |
SELL
|
- |
-1.4K- 1.72% |
$672 - $896
|
79.9K
$125K
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
SELL
|
- |
-6.72K- 99.61% |
$3.22K - $4.3K
|
26
$40.8
|
|
May 12, 2023
Q1 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-14.5K- 14.95% |
$6.96K - $9.28K
|
82.5K
$129K
|
|
Jun 01, 2023
Q1 2023
|
Golden State Equity Partners
South Coast Metro, CA |
SELL
|
- |
-22.1KClosed |
$10.6K - $14.2K
|
0
$0
|
|
May 15, 2023
Q1 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-22.7K- 4.6% |
$10.9K - $14.6K
|
471K
$740K
|
|
May 15, 2023
Q1 2023
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
SELL
|
- |
-680K- 58.68% |
$326K - $435K
|
479K
$752K
|